Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 926544
                    [Title] => Experts highlight vildagliptin’s novel mechanism of action
                    [Summary] => 
With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

                    [DatePublished] => 2013-04-04 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 323056
                    [Title] => WHO lauds RP campaign vs diabetes
                    [Summary] => HANOI — The Philippines has been acknowledged by the World Health Organization (WHO) for its active campaigning against non-communicable diseases (NCDs), including diabetes, at a summit here.


In a presentation during the Diabetes Summit last Tuesday, Dr. Gauden Galea, WHO regional adviser for NCDs in the Western Pacific, said the Philippines is among the countries in the region that need "external intervention (support)" in battling NCDs, but noted it is doing well in the campaign.


The other nations he cited were China, Mongolia and  Vietnam.


                    [DatePublished] => 2006-02-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

DIABETES SUMMIT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 926544
                    [Title] => Experts highlight vildagliptin’s novel mechanism of action
                    [Summary] => 
With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

                    [DatePublished] => 2013-04-04 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 323056
                    [Title] => WHO lauds RP campaign vs diabetes
                    [Summary] => HANOI — The Philippines has been acknowledged by the World Health Organization (WHO) for its active campaigning against non-communicable diseases (NCDs), including diabetes, at a summit here.


In a presentation during the Diabetes Summit last Tuesday, Dr. Gauden Galea, WHO regional adviser for NCDs in the Western Pacific, said the Philippines is among the countries in the region that need "external intervention (support)" in battling NCDs, but noted it is doing well in the campaign.


The other nations he cited were China, Mongolia and  Vietnam.


                    [DatePublished] => 2006-02-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

abtest

Experts highlight vildagliptin’s novel mechanism of action

April 4, 2013 - 12:00am

With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

Science and Environment

WHO lauds RP campaign vs diabetes

By Sheila Crisostomo | February 24, 2006 - 12:00am

HANOI — The Philippines has been acknowledged by the World Health Organization (WHO) for its active campaigning against non-communicable diseases (NCDs), including diabetes, at a summit here. In a presentation...

Headlines